...
search icon
vstm-img

Verastem Inc Share Price

VSTM
NAQ
$5.741
-$0.12
(-2.05%)
1D
Industry: Biotechnology Sector: Health Care

Verastem Inc Analyst Forecast

Verastem Inc Share Price Chart

Verastem Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$441.37M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.48M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.39
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.01 L
$11.25 H
$5.741

About Verastem Inc, Common Stock

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma RAF/MEK, ERK mitogen activated pathway kinase pathway which is involved in cell proliferation, migration, transformation, and survival of tumor cells; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors. The company is involved in clinical studies, including RAMP 301, a randomized global confirmatory trial to evaluate the combination of Avutometinib and Defactinib for the treatment of patients with recurrent low-grade serous ovarian cancer; RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of Avutometinib and in combination with Defactinib; and FRAME, an investigation of Avutometinib and Defactinib in patients with KRAS mutant cancers and subsequent analyses; and RAMP 204 and 205. It has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing Avutometinib; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic, and prophylactic uses in humans. In addition, it has a clinical collaboration agreement with Amgen, Inc. to evaluate the combination of Avutometinib with Amgen's KRAS-G12C inhibitor LUMAKRAS which in Phase 1/2 trial entitled RAMP 203; and a discovery and development collaboration with GenFleet Therapeutics to advance new programs targeting RAS pathway-driven cancers. Verastem, Inc. was incorporated in 2010 and is headquartered in Needham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Verastem Inc Stock Returns

Time FrameVSTMSectorS&P500
1-Week Return-9.94%0.72%-1.31%
1-Month Return-14.14%1.27%0.78%
3-Month Return-38.4%3.13%3.46%
6-Month Return-28.36%15.81%6.19%
1-Year Return-0.52%8.89%11.68%
3-Year Return-9.93%20.79%71.21%
5-Year Return-83.07%35.89%74.81%
10-Year Return-63.11%138.44%256.59%

Verastem Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue88.52M2.05M2.60M-10.00M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":2.32,"profit":true},{"date":"2022-12-31","value":2.93,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":11.3,"profit":true}]
Cost of Revenue33.74M206.00K118.00K62.00K26.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":0.61,"profit":true},{"date":"2022-12-31","value":0.35,"profit":true},{"date":"2023-12-31","value":0.18,"profit":true},{"date":"2024-12-31","value":0.08,"profit":true}]
Gross Profit54.77M2.05M2.60M(62.00K)10.00M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":3.75,"profit":true},{"date":"2022-12-31","value":4.74,"profit":true},{"date":"2023-12-31","value":-0.11,"profit":false},{"date":"2024-12-31","value":18.26,"profit":true}]
Gross Margin61.88%100.00%100.00%-100.00%[{"date":"2020-12-31","value":61.88,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses104.13M63.46M75.53M92.08M124.96M[{"date":"2020-12-31","value":83.33,"profit":true},{"date":"2021-12-31","value":50.79,"profit":true},{"date":"2022-12-31","value":60.45,"profit":true},{"date":"2023-12-31","value":73.69,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(49.36M)(61.41M)(72.94M)(92.08M)(114.96M)[{"date":"2020-12-31","value":-4936000000,"profit":false},{"date":"2021-12-31","value":-6140900000,"profit":false},{"date":"2022-12-31","value":-7293700000,"profit":false},{"date":"2023-12-31","value":-9208400000,"profit":false},{"date":"2024-12-31","value":-11495600000,"profit":false}]
Total Non-Operating Income/Expense(33.45M)(19.58M)(1.80M)6.09M(15.91M)[{"date":"2020-12-31","value":-549.46,"profit":false},{"date":"2021-12-31","value":-321.65,"profit":false},{"date":"2022-12-31","value":-29.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-261.32,"profit":false}]
Pre-Tax Income(67.53M)(71.20M)(73.81M)(87.37M)(130.45M)[{"date":"2020-12-31","value":-6753200000,"profit":false},{"date":"2021-12-31","value":-7120000000,"profit":false},{"date":"2022-12-31","value":-7381200000,"profit":false},{"date":"2023-12-31","value":-8736700000,"profit":false},{"date":"2024-12-31","value":-13045200000,"profit":false}]
Income Taxes194.00K9.90M36.00K(87.37M)185.00K[{"date":"2020-12-31","value":1.96,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.36,"profit":true},{"date":"2023-12-31","value":-882.49,"profit":false},{"date":"2024-12-31","value":1.87,"profit":true}]
Income After Taxes(67.73M)(81.10M)(73.85M)-(130.64M)[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Income From Continuous Operations(67.73M)(71.20M)(73.81M)(76.81M)(130.64M)[{"date":"2020-12-31","value":-6772600000,"profit":false},{"date":"2021-12-31","value":-7120000000,"profit":false},{"date":"2022-12-31","value":-7381200000,"profit":false},{"date":"2023-12-31","value":-7680700000,"profit":false},{"date":"2024-12-31","value":-13063700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(67.73M)(71.20M)(73.81M)(87.37M)(130.64M)[{"date":"2020-12-31","value":-6772600000,"profit":false},{"date":"2021-12-31","value":-7120000000,"profit":false},{"date":"2022-12-31","value":-7381200000,"profit":false},{"date":"2023-12-31","value":-8736700000,"profit":false},{"date":"2024-12-31","value":-13063700000,"profit":false}]
EPS (Diluted)(0.39)(0.41)(0.38)(3.22)(2.77)[{"date":"2020-12-31","value":-39,"profit":false},{"date":"2021-12-31","value":-41,"profit":false},{"date":"2022-12-31","value":-38,"profit":false},{"date":"2023-12-31","value":-322,"profit":false},{"date":"2024-12-31","value":-277,"profit":false}]

Verastem Inc Ratios

Verastem Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

VSTM
Cash Ratio 2.31
Current Ratio 2.58
Quick Ratio 2.55

Verastem Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VSTM
ROA (LTM) -66.06%
ROE (LTM) -2888.71%

Verastem Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VSTM
Debt Ratio Lower is generally better. Negative is bad. 1.09
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.09

Verastem Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VSTM
Trailing PE NM
Forward PE NM
P/S (TTM) 32.76
P/B 15.35
Price/FCF NM
EV/R 29.16
EV/Ebitda NM
PEG NM

FAQs

What is Verastem Inc share price today?

Verastem Inc (VSTM) share price today is $5.741

Can Indians buy Verastem Inc shares?

Yes, Indians can buy shares of Verastem Inc (VSTM) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VSTM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Verastem Inc be purchased?

Yes, you can purchase fractional shares of Verastem Inc (VSTM) via the Vested app. You can start investing in Verastem Inc (VSTM) with a minimum investment of $1.

How to invest in Verastem Inc shares from India?

You can invest in shares of Verastem Inc (VSTM) via Vested in three simple steps:

  • Click on Sign Up or Invest in VSTM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Verastem Inc shares
What is Verastem Inc 52-week high and low stock price?

The 52-week high price of Verastem Inc (VSTM) is $11.25. The 52-week low price of Verastem Inc (VSTM) is $4.01.

What is Verastem Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Verastem Inc (VSTM) is

What is Verastem Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Verastem Inc (VSTM) is 15.35

What is Verastem Inc dividend yield?

The dividend yield of Verastem Inc (VSTM) is 0.00%

What is the Market Cap of Verastem Inc?

The market capitalization of Verastem Inc (VSTM) is $441.37M

What is Verastem Inc's stock symbol?

The stock symbol (or ticker) of Verastem Inc is VSTM

How Can Investors Use Verastem Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Verastem Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Verastem Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Verastem Inc shares for Indian investors?

When investing in Verastem Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Verastem Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Verastem Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Verastem Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Verastem Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top